This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2025 May 12;32(7):608-609.

doi: 10.1093/eurjpc/zwad219.

Orthostatic hypertension is an accessible, low-cost marker of cardiovascular risk

Leah Rethy¹

Affiliations

Affiliation

¹ Division of Cardiology, Department of Medicine, University of Pennsylvania, Perelman Center for Advanced Medicine, 3400 Civic Center Boulevard, Philadelphia, PA 19104, USA.

PMID: 37390468
DOI: 10.1093/eurjpc/zwad219

Editorial

Orthostatic hypertension is an accessible, low-cost marker of cardiovascular risk

Leah Rethy. Eur J Prev Cardiol. 2025.

. 2025 May 12;32(7):608-609.

doi: 10.1093/eurjpc/zwad219.

Author

Leah Rethy¹

Affiliation

¹ Division of Cardiology, Department of Medicine, University of Pennsylvania, Perelman Center for Advanced Medicine, 3400 Civic Center Boulevard, Philadelphia, PA 19104, USA.

PMID: 37390468
DOI: 10.1093/eurjpc/zwad219

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Comment on

Orthostatic hypertension and major adverse events: a systematic review and meta-analysis.
Pasdar Z, De Paola L, Carter B, Pana TA, Potter JF, Myint PK. Pasdar Z, et al. Eur J Prev Cardiol. 2023 Aug 1;30(10):1028-1038. doi: 10.1093/eurjpc/zwad158. Eur J Prev Cardiol. 2023. PMID: 37202364

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems